ASPIRE set up to collaborate on amyloidosis
A new group of biotech and pharma companies has been assembled by the Amyloidosis Research…
October 4, 2022 - 3 minutes
Johnson & Johnson
Hope for children with chronic graft versus host disease as Johnson & Johnson drug approved
A treatment for chronic graft versus host disease in children aged one year and older…
August 25, 2022 - 3 minutes
Yumanity selling neurology assets and merging with Kineta
U.S. biopharma company Yumanity Therapeutics, Inc. is selling off its lead clinical-stage neurodegenerative product candidate…
June 7, 2022 - 3 minutes
As J&J Vaccine Fails Phase II, the Quest for an HIV Vaccine Continues
Johnson & Johnson became the latest company to have a failed vaccine trial against HIV…
September 8, 2021 - 5 minutes
EMA Approvals for Multiple Sclerosis Highlight Treatment Shortfalls
While the EU saw rapid-fire approvals in the multiple sclerosis space last month, the innovations…
April 27, 2021 - 6 minutes
This Incubator Knows How to Get Biotechs Started
When it comes to drug discovery and development, nowadays a lot of the work is…
December 10, 2018 - 6 minutes
Check Out Europe’s Hottest Pitching Event for Startups!
Last year Berlin, this year Copenhagen - No matter where in Europe, this is the…
September 5, 2018 - 5 minutes
The Startup Slam at BIO-Europe 2017! Choosing the Winner was Hard!
What would a large event like BIO-Europe be without startups? They’re not only the life…
December 13, 2017 - 4 minutes
UK-based VC Launches Massive $300M Fund to Fill Gap for Late-Stage Biotech
The UK-based VC Medicxi has raised a massive $300M (€268M) fund backed by Novartis and…
June 15, 2017 - 3 minutes
Which European Blockbusters Topped the Charts in 2016?
Blockbuster drugs are raking in billions each year in sales. Let's have a look at the top…
March 8, 2017 - 4 minutes
Actelion’s key Drug linked to Deaths, prompting EMA Investigation
Johnson & Johnson is certainly counting on its recent acquisition of the European biotech success Actelion…
February 15, 2017 - 3 minutes
Europe’s Largest Biotech Actelion Seals the Deal with J&J for €28B
Actelion will be acquired by J&J for a whopping €27.9B, and its early R&D pipeline…
January 26, 2017 - 2 minutes
